Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain
1 other identifier
observational
200
1 country
2
Brief Summary
This study aims to identify spatiotemporal alterations in thalamocortical circuitry functioning in both healthy subjects and patients with chronic pain, combining multimodal neuroimaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2023
CompletedFirst Posted
Study publicly available on registry
March 10, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 23, 2023
March 1, 2023
1.5 years
February 28, 2023
March 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
thalamocortical functional connectivity
functional connectivity between the thalamus and cortex as measured by resting state fMRI
baseline
alpha oscillations
alpha oscillations as measured by EEG and MEG
baseline
Secondary Outcomes (1)
alpha band source
Baseline
Study Arms (2)
Healthy Control
Healthy participants will undergo multimodal neuroimaging during resting state, no-pain and painful tonic pressure presentation. At FSU, EEG and fMRI will be simultaneously acquired. At MGH, sequential MRI and MEG/EEG will be acquired.
Patients with chronic low back pain
Subjects with chronic low back pain (cLBP) patients will undergo multimodal neuroimaging during resting state, no-pain and painful tonic pressure presentation. The study will only be performed at MGH, sequential MRI and MEG/EEG will be acquired.
Interventions
No intervention involved in this study
Eligibility Criteria
Healthy subjects and individuals with chronic low back pain
You may qualify if:
- healthy male and female adults
- Between the ages of 18 and 60 years
- Meeting the MRI / MEG / EEG screening criteria
- Fluent in English; English can be a second language provided that the patients understand all questions used in the assessment measures. This will be asked and judged during the phone screen.
You may not qualify if:
- Current or past history of major medical, neurological, or psychiatric illness based on self-report
- History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia)
- History of head trauma
- Pregnant or lactating
- Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner)
- Conditions making study participation difficult (e.g., paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1)
- Active substance abuse disorders (based on subject self-report)
- Subjects with chronic low back pain (MGH site)
- Volunteers 18-60 years of age
- Meet the Classification Criteria of the chronic LBP (having low back pain for more than 6 months)
- At least 4/10 clinical pain on the 0-10 LBP NRS
- Meeting the MRI / MEG / EEG screening criteria
- Fluent in English; English can be a second language provided that the patients understand all questions used in the assessment measures. This will be asked and judged during the phone screen.
- Specific causes of back pain (eg, cancer, fractures, spinal stenosis, infections)
- Complicated back problems (eg, prior back surgery, medicolegal issues)
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Florida State Universitycollaborator
Study Sites (2)
Florida State University
Tallahassee, Florida, 323060000, United States
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 28, 2023
First Posted
March 10, 2023
Study Start
May 1, 2023
Primary Completion
October 30, 2024
Study Completion
December 31, 2024
Last Updated
March 23, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share